2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
43
Liver Neoplasms
14
Colorectal Neoplasms
10
Recurrence
6
Cholangiocarcinoma
6
Neoplasm Metastasis
5
Pancreatic Neoplasms
3
Colonic Neoplasms
3
Rupture, Spontaneous
2
Postoperative Complications
2
Tissue Adhesions
1
Stomach Neoplasms
1
Secondary Malignant Neoplasm of Liver
1
Sarcopenia
1
Reperfusion Injury
1
Obesity, Morbid
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Metabolic Syndrome
1
Long-term Effects of Cancer Treatment
1
Liver Surgery
1
Liver Failure
1
Klatskin Tumor
1
Ischemia
1
Hypertension, Portal
1
Hemangioma
1
Focal Nodular Hyperplasia
1
Fibrosis
1
Disseminated Pancreatic Cancer
1
Disease Progression
1
Interventions
veliparib
1
urinastatin
1
sacituzumab govitecan
1
maltodextrin
1
halofantrine
1
Taxes
1
Raltegravir Potassium
1
Paclitaxel
1
N-monoacetylcystine
1
Hepatectomy
1
Glycyrrhizic Acid
1
Everolimus
1
Carboplatin
1
Blood Specimen Collection
1
Amino Acids
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Failure
×
Hepatectomy
×
Clear all
NCT04705194
2021-01-22
HEPARIM
University of Leeds
Unknown
134 enrolled